Firm's vision is to harness power of microorganisms as a sustainable platform to produce proteins now derived from animals ...

Caterpillar CAT stock rose toward closing with a market cap of more than $300 billion for the first time ever, according to ...

Travere Therapeutics Stock (TVTX) is plummeting on news of a potential FDA delay for its kidney disease treatment ...

Rare Pediatric Disease Priority Review Voucher (PRV) granted by FDA at approval to be transferred from Sentynl Therapeutics to Cyprium Cyprium eligible to receive tiered royalties and up to $129 milli ...

Rare Pediatric Disease Priority Review Voucher (PRV) granted by FDA at approval to be transferred from Sentynl Therapeutics ...

The U.S. Food and Drug Administration approved Fortress Biotech and Indian drugmaker Zydus Lifesciences' drug ​for children ...

For the last two years, the cultivated meat industry has been experiencing growing pains. Many startups have shrunk, shut ...

At a STAT event, veteran drug regulator Richard Pazdur, who left the FDA last month after 26 years, said that politics and ...

Dynavax said its board determined the undisclosed bidder's offer was unlikely to lead to a superior proposal to Sanofi's bid. There was substantial risk of Sanofi withdrawing from discussions and ...

Vetr.com, a veterinary technology company and veterinary treatment manufacturer, announced today that more than 1,000 ...

The company also announced the appointment of Han Lee, Ph.D., as co-chief executive officer (CEO), and the U.S. Food and Drug ...